Immunic, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Immunic, Inc. (IMUX) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$41.47 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-04.
Discontinued › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2019-03-04
- Immunic, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2018 was -$41.47M.
- Immunic, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2017 was -$52.07M.
- Immunic, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2016 was -$40.93M.
- Immunic, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2015 was -$51.78M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2018-12-31 | -$41.47M 10-K · filed 2019-03-04 |
| 2017-12-31 | -$52.07M 10-K · filed 2019-03-04 |
| 2016-12-31 | -$40.93M 10-K · filed 2019-03-04 |
| 2015-12-31 | -$51.78M 10-K · filed 2018-03-13 |
| 2014-12-31 | -$47.48M 10-K · filed 2017-03-07 |
| 2013-12-31 | -$32.52M 10-K · filed 2016-03-08 |
| 2012-12-31 | -$6.32M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |